David Mirelman

13.4k total citations · 2 hit papers
223 papers, 10.9k citations indexed

About

David Mirelman is a scholar working on Infectious Diseases, Parasitology and Molecular Biology. According to data from OpenAlex, David Mirelman has authored 223 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Infectious Diseases, 80 papers in Parasitology and 69 papers in Molecular Biology. Recurrent topics in David Mirelman's work include Amoebic Infections and Treatments (108 papers), Parasitic Infections and Diagnostics (79 papers) and Garlic and Onion Studies (32 papers). David Mirelman is often cited by papers focused on Amoebic Infections and Treatments (108 papers), Parasitic Infections and Diagnostics (79 papers) and Garlic and Onion Studies (32 papers). David Mirelman collaborates with scholars based in Israel, United States and Germany. David Mirelman's co-authors include Nathan Sharon, Serge Ankri, Rivka Bracha, Itzhak Ofek, Meir Wilchek, Talia Miron, Aharon Rabinkov, Yael Nuchamowitz, Lev Weiner and Tamara Stolarsky and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

David Mirelman

218 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimicrobial properties of allicin from garlic

1999 883 citations Serge Ankri, David Mirelman Microbes and Infection profile →
Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors

1977 558 citations David Mirelman et al. profile →

Peers

Countries citing papers authored by David Mirelman

Since Specialization

Citations

This map shows the geographic impact of David Mirelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mirelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mirelman more than expected).

Fields of papers citing papers by David Mirelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Mirelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mirelman. The network helps show where David Mirelman may publish in the future.

Co-authorship network of co-authors of David Mirelman

This figure shows the co-authorship network connecting the top 25 collaborators of David Mirelman. A scholar is included among the top collaborators of David Mirelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Mirelman. David Mirelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MRS of Brain Metabolite Levels Demonstrates the Ability of Scavenging of Excess Brain Glutamate to Protect against Nerve Agent Induced Seizures 2015 ·International Journal of Molecular Sciences ·Angela Ruban, Inbal Biton, (unknown), David Mirelman	12
2	Trophozoites ofEntamoeba histolyticaepigenetically silenced in several genes are virulence-attenuated 2008 ·Parasite ·David Mirelman, M. Anbar, Rivka Bracha	12
3	EhLimA, a Novel LIM Protein, Localizes to the Plasma Membrane in Entamoeba histolytica 2007 ·Eukaryotic Cell ·(unknown), Eduardo Villalobo, David Mirelman	17
4	Involvement of a Short Interspersed Element in Epigenetic Transcriptional Silencing of the Amoebapore Gene in Entamoeba histolytica 2005 ·Eukaryotic Cell ·Michael Anbar, Rivka Bracha, Yael Nuchamowitz, Yan Li, Anat Florentin, David Mirelman	40
5	Entamoeba histolytica: Molecular characterization of an aldose 1-epimerase (mutarotase) 2005 ·Experimental Parasitology ·Eduardo Villalobo, (unknown), David Mirelman	2
6	A virulence attenuated amoebapore-less mutant of Entamoeba histolytica and its interaction with host cells 2003 ·International Journal for Parasitology ·(unknown), Uriel Katz, Rivka Bracha, David Mirelman	36
7	Entamoeba histolytica Schaudinn, 1903 and Entamoeba dispar Brumpt, 1925: Differences in their Cell Surfaces and in the Bacteria‐containing Vacuoles 2002 ·Journal of Eukaryotic Microbiology ·Paulo Filemon Paolucci Pimenta, Louis S. Diamond, David Mirelman	26
8	Entamoeba histolytica Expressing a Dominant Negative N-Truncated Light Subunit of Its Gal-Lectin Are Less Virulent 2002 ·Molecular Biology of the Cell ·Uriel Katz, Serge Ankri, Tamara Stolarsky, Yael Nuchamowitz, David Mirelman	38
9	Antimicrobial properties of allicin from garlic breakdown → 1999 ·Microbes and Infection ·Serge Ankri, David Mirelman	883
10	Antisense inhibition of amoebapore expression inEntamoeba histolyticacauses a decrease in amoebic virulence 1999 ·Molecular Microbiology ·Rivka Bracha, Yael Nuchamowitz, Matthias Leippe, David Mirelman	86
11	Identification of Significant Variation in the Composition of Lipophosphoglycan‐like Molecules of E. histolytica and E. dispar1 1998 ·Journal of Eukaryotic Microbiology ·Susan F. Moody, (unknown), Yael Nuchamowitz, David Mirelman	24
12	Antisense inhibition of expression of cysteine proteinases does not affect Entamoeba histolytica cytopathic or haemolytic activity but inhibits phagocytosis 1998 ·Molecular Microbiology ·Serge Ankri, Tamara Stolarsky, David Mirelman	104
13	Characterization of 20 entamoeba histolytica strains isolated from patients with HIV infection 1991 ·Infection ·G. D. Burchard, F. Hufert, David Mirelman	12
14	Cloning and characterization of an unusual elongation factor-1α cDNA from Entamoeba histolytica 1991 ·Molecular and Biochemical Parasitology ·(unknown), Rivka Bracha, Marcel Huber, (unknown), Shmuel Rozenblatt, David Mirelman	23
15	Nonimmunoglobulin Fraction of Human Milk Inhibits the Adherence of Certain Enterotoxigenic Escherichia coli Strains to Guinea Pig Intestinal Tract 1987 ·Pediatric Research ·Shai Ashkenazi, David Mirelman	37
16	Microbial lectins and agglutinins : properties and biological activity 1986 ·Wiley eBooks ·David Mirelman	97
17	Virulence of Entamoeba histolytica trophozoites. Effects of bacteria, microaerobic conditions, and metronidazole. 1984 ·The Journal of Experimental Medicine ·Rivka Bracha, David Mirelman	160
18	The effects of cefotaxime and mecillinam on the terminal stages of Escherichia coli peptidoglycan synthesis 1983 ·FEMS Microbiology Letters ·Helmut Mett, David Mirelman	1
19	Carbohydrate Recognition Mechanisms which Mediate Microbial Adherence to Mammalian Mucosal Surfaces(MEMBRANE PROTEINS IN CELLULAR INTERACTIONS) 1982 ·David Mirelman, Mordechai Izhar, Yuval Eshdat	0
20	A lectin activity in Entamoeba histolytica trophozoites. 1980 ·PubMed ·David Kobiler, David Mirelman	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact